Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke

Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke

Abstract Background Stroke is a leading cause of death and disability, and despite intensive research, few treatment options exist. However, a recent breakthrough in cell therapy is expected to reverse the neurological sequelae of stroke. Although some pioneer studies on the use of cell therapy for...

Full description

Bibliographic Details
Main Authors: Hideo Shichinohe, Masahito Kawabori, Hiroaki Iijima, Tuyoshi Teramoto, Takeo Abumiya, Naoki Nakayama, Ken Kazumata, Shunsuke Terasaka, Teruyo Arato, Kiyohiro Houkin
Format: Article
Language:English
Published: BMC 2017-09-01
Series:BMC Neurology
Subjects:
Acute ischemic stroke
Bone marrow stromal cells
Cell therapy
Regenerative medicine
Intraparenchymal injection
Platelet lysate
Online Access:http://link.springer.com/article/10.1186/s12883-017-0955-6

Internet

http://link.springer.com/article/10.1186/s12883-017-0955-6

Similar Items